Current filters:  
Canada
Healthcare
Canada
Bereskin & Parr LLP
As now widely recognized, the primary active ingredient found in magic mushrooms, psilocybin, has significant potential for treating many mental health disorders.
Langlois lawyers, LLP
Le 17 février 2021, le ministère de la Santé et des Services sociaux du Québec (ci-après le « MSSS ») annonçait que dans certaines circonstances...
Gowling WLG
What happens when a generic or biosimilar enters a market where patents are in force? What preliminary measures exist?
Smart & Biggar
On January 29, 2021, the Alberta Court of Appeal dismissed Allergan's appeal of a judicial review decision relating to the interchangeability of its glaucoma drug LUMIGAN RC (0.01% bimatoprost)...
Miller Thomson LLP
Public hospitals in Ontario continue to collaborate with healthcare and community partners to build system capacity in responding to COVID-19.
Siskinds LLP
It has never been easier to keep track of personal health and fitness. Individuals now have access to hundreds of health-related apps at their fingertips,...
Siskinds LLP
Hand sanitizer recall sparks concern … Red onion recall expands across Canada due to Salmonella outbreak… Additional ranitidine products recalled worldwide...
Torys LLP
This video is the fourth and final in a series which will explain the legal framework of the health care system, and regulation of drugs and drug pricing,...
Torys LLP
This video is the third in a series of four which will explain the legal framework of the health care system, and regulation of drugs and drug pricing, in Canada at the ...
Gowling WLG
On February 2, 2021, Precision NanoSystems, Inc. ("PNI") announced that it had received a contribution of $25.1 million through the Government of Canada's Strategic Innovation Fund (SIF).
Littler - Canada
On February 8, 2021, Ontario issued a news release announcing that it would be moving to a regional approach regarding its COVID-19 response.
Miller Thomson LLP
Keeping up to speed with changes in the world of health professional regulation in Alberta will keep almost anyone working in healthcare busy in 2021.
Torys LLP
This video is the third in a series of four which will explain the legal framework of the health care system, and regulation of drugs and drug pricing, in Canada at the federal and provincial...
Gowling WLG
On January 29, 2021, the Alberta Government introduced a four-step framework (the "Framework") to ease the mandatory health restrictions announced on December 8, 2020 based on certain...
Smart & Biggar
The U.S. Food and Drug Administration (FDA) Oncology Center of Excellence recently published an overview of Project Orbis
Torys LLP
This video is the second in a series of four which will explain the legal framework of the health care system, and regulation of drugs and drug pricing, in Canada at the federal and provincial levels.
MLT Aikins LLP
On October 30 the Government of Manitoba announced province-wide changes to its #RestartMB Pandemic Response System in response to the surge of confirmed COVID-19 cases and the...
Norton Rose Fulbright Canada LLP
The Canadian pharma and life sciences space saw many developments in 2020, despite and in some cases because of the COVID-19 pandemic.
Torys LLP
This video is the first in a series of four which will explain the legal framework of the health care system, and regulation of drugs and drug pricing, in Canada at the federal and provincial levels.
Torys LLP
In 2014 the Canadian federal government passed Bill C-17, known as Vanessa's Law, amending the Food and Drugs Act and increasing Health Canada's
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Upcoming Events
MAR25
Webinar Boston United States
Tools
Font Size:
Translation
Mondaq Social Media